Associations between lifestyle factors and hand eczema severity: are tobacco smoking, obesity and stress significantly linked to eczema severity?

Autor: Sørensen JA; Department of Occupational and Environmental Medicine, Bispebjerg University Hospital, 2400, Copenhagen, Denmark.; Department of Dermatology, Bispebjerg University Hospital, 2400, Copenhagen, Denmark., Fisker MH; Department of Occupational and Environmental Medicine, Bispebjerg University Hospital, 2400, Copenhagen, Denmark., Agner T; Department of Dermatology, Bispebjerg University Hospital, 2400, Copenhagen, Denmark., Clemmensen KK; Department of Dermatology, Bispebjerg University Hospital, 2400, Copenhagen, Denmark., Ebbehøj NE; Department of Occupational and Environmental Medicine, Bispebjerg University Hospital, 2400, Copenhagen, Denmark.

Publikováno v: Contact dermatitis [Contact Dermatitis] 2017 Mar; Vol. 76 (3), pp. 138-145. Date of Electronic Publication: 2016 Oct 06.

Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).

Autor: Chalmers JR; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K., Simpson E; Department of Dermatology, Oregon Health and Science University, Portland, OR, U.S.A., Apfelbacher CJ; Medical Sociology, Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany., Thomas KS; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K., von Kobyletzki L; Lund University, Skåne University Hospital, Department of Dermatology, Malmö, Sweden.; Department of Public Health Sciences, Karlstad University, Karlstad, Sweden., Schmitt J; Centre for Evidence-Based Healthcare, University of Dresden, Dresden, Germany.; Department of Occupational and Social Medicine, Technical University Dresden, Dresden, Germany., Singh JA; Medicine Service, Birmingham VA Medical Center, Birmingham, AL, U.S.A.; Department of Medicine, University of Alabama, Birmingham, AL, U.S.A., Svensson Å; Department of Dermatology and Venereology, Malmö University Hospital, Malmö, Sweden., Williams HC; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K., Abuabara K; Department of Dermatology, University of California San Francisco, San Francisco, California, CA, U.S.A., Aoki V; Department of Dermatology, University of São Paulo Medical School, São Paulo, Brazil., Ardeleanu M; Immunology and Inflammation, Regeneron Pharmaceuticals, Inc., New York, NY, U.S.A., Awici-Rasmussen M; Psoriasis and Eczema Association of Norway, Oslo, Norway., Barbarot S; Department of Dermatology, CHU de Nantes, Nantes, France., Berents TL; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Dermatology, Oslo University Hospital, Oslo, Norway., Block J; National Eczema Organisation, National Eczema Association, San Rafael, CA, U.S.A., Bragg A; Chugai Pharma Europe Ltd., London, U.K., Burton T; No affiliation (patient representative U.K.)., Bjerring Clemmensen KK; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark., Creswell-Melville A; Société Canadienne de l'Eczéma, Keswick, ON, Canada., Dinesen M; LEO Pharma A/S, Industriparken 55, Ballerup, Denmark., Drucker A; Division of Dermatology, University Health Network, Toronto, ON, Canada., Eckert L; Health Economics and Outcomes Research, Sanofi, France., Flohr C; St John's Institute of Dermatology, Guy's and St Thomas' Hospitals NHS Foundation Trust and King's College London, London, U.K., Garg M; LEO Pharma, Copenhagen, Denmark., Gerbens LA; Department of Dermatology, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands., Graff AL; National Eczema Society, London, U.K., Hanifin J; Department of Dermatology, Oregon Health and Science University, Portland, OR, U.S.A., Heinl D; Medical Sociology, Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany., Humphreys R; National Eczema Society, London, U.K., Ishii HA; Brazilian Atopic Dermatitis Association (AADA), São Paulo, Brazil., Kataoka Y; Osaka Prefectural Medical Center for Respiratory and Allergic Disease, Osaka, Japan., Leshem YA; Department of Dermatology, Oregon Health and Science University, Portland, OR, U.S.A., Marquort B; No affiliation (patient representative Sweden)., Massuel MA; Sanofi-Aventis, Paris, France., Merhand S; Association Française de l'Eczéma, Redon, France., Mizutani H; Mie University, Graduate School of Medicine and Mie University Hospital Tsu, Mie, Japan., Murota H; Department of Dermatology, Osaka University, Osaka, Japan., Murrell DF; Department of Dermatology, St George Hospital, Sydney, Australia.; University of New South Wales, Sydney, Australia., Nakahara T; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Nasr I; Retired, no affiliation., Nograles K; Celgene Corporation, Greater New York City Area Pharmaceuticals, New York, NY, U.S.A., Ohya Y; Division of Allergy, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan., Osterloh I; Ostermed Ltd., Kent, U.K., Pander J; Celgene BV, Utrecht, the Netherlands., Prinsen C; Department of Epidemiology and Biostatistics, EMGO+ Institute for Health and Care Research, VU University Medical Centre, Amsterdam, the Netherlands., Purkins L; Ziarco Pharma Ltd, Kent, U.K., Ridd M; School of Social & Community Medicine, University of Bristol, Bristol, U.K., Sach T; Health Economics Group, University of East Anglia, Norwich, U.K., Schuttelaar ML; Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Shindo S; Department of Dermatology, Osaka University, Osaka, Japan., Smirnova J; Department of Public Health Sciences, Karlstad University, Karlstad, Sweden., Sulzer A; Sanofi-Aventis, Montpellier, France., Synnøve Gjerde E; Psoriasis and Eczema Association of Norway, Oslo, Norway., Takaoka R; Department of Dermatology, University of São Paulo Medical School, São Paulo, Brazil., Vestby Talmo H; Sanofi-Aventis, Montpellier, France., Tauber M; Toulouse University, Toulouse, France., Torchet F; Mie University, Graduate School of Medicine and Mie University Hospital Tsu, Mie, Japan., Volke A; Department of Dermatology, University of Tartu, Tartu, Estonia., Wahlgren CF; Dermatology Unit, Department of Medicine, Karolinska Institutet, Solna, Sweden.; Karolinska University Hospital, Stockholm, Sweden., Weidinger S; Department of Dermatology, Venereology and Allergy University Hospital Schleswig-Holstein, Kiel, Germany., Weisshaar E; Occupational and Environmental Dermatology, Department of Social Medicine, University of Heidelberg, Heidelberg, Germany., Wollenberg A; Department of Dermatology and Allergy, Ludwig-Maximilian University, Munich, Germany., Yamaga K; Department of Dermatology, Osaka University, Osaka, Japan., Zhao CY; Department of Dermatology, St George Hospital, Sydney, Australia.; University of New South Wales, Sydney, Australia., Spuls PI; Department of Dermatology, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2016 Jul; Vol. 175 (1), pp. 69-79. Date of Electronic Publication: 2016 Jul 19.

Outcome of treatment with azathioprine in severe atopic dermatitis: a 5-year retrospective study of adult outpatients.

Autor: Thomsen SF; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark. simonfrancisthomsen@gmail.com., Karlsmark T, Clemmensen KK, Graversgaard C, Ibler KS, Jemec GB, Agner T

Publikováno v: The British journal of dermatology [Br J Dermatol] 2015 Apr; Vol. 172 (4), pp. 1122-4. Date of Electronic Publication: 2015 Feb 25.

Pattern of contact sensitization in patients with and without atopic dermatitis in a hospital-based clinical database.

Autor: Clemmensen KK; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, 2400, Copenhagen NV, Denmark., Thomsen SF, Jemec GB, Agner T

Publikováno v: Contact dermatitis [Contact Dermatitis] 2014 Aug; Vol. 71 (2), pp. 75-81. Date of Electronic Publication: 2014 Apr 04.

The circadian schedule for childhood acute lymphoblastic leukemia maintenance therapy does not influence event-free survival in the NOPHO ALL92 protocol.

Autor: Clemmensen KK; Clinic for Pediatrics and Adolescent Medicine, The Juliane Marie Centre, The University Hospital Rigshospitalet, Copenhagen, Denmark., Christensen RH, Shabaneh DN, Harila-Saari A, Heyman M, Jonsson OG, Wesenberg F, Rosthøj S, Schmiegelow K

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2014 Apr; Vol. 61 (4), pp. 653-8. Date of Electronic Publication: 2013 Nov 22.